$9.05
8.12% yesterday
Nasdaq, Aug 21, 10:00 pm CET
ISIN
US0352551081
Symbol
ANIK

Anika Therapeutics, Inc. Stock price

$9.05
-1.64 15.34% 1M
-8.34 47.96% 6M
-7.41 45.02% YTD
-16.63 64.76% 1Y
-13.73 60.27% 3Y
-27.34 75.13% 5Y
-25.83 74.05% 10Y
-4.56 33.50% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.68 8.12%
ISIN
US0352551081
Symbol
ANIK
Industry

Key metrics

Basic
Market capitalization
$130.5m
Enterprise Value
$77.3m
Net debt
positive
Cash
$53.2m
Shares outstanding
14.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 1.2
EV/Sales
0.6 | 0.7
EV/FCF
negative
P/B
0.9
Financial Health
Equity Ratio
76.0%
Return on Equity
-36.6%
ROCE
-6.4%
ROIC
-9.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$123.7m | $112.2m
EBITDA
$-3.9m | $773.7k
EBIT
$-10.9m | $-16.3m
Net Income
$-60.6m | $-16.2m
Free Cash Flow
$-1.1m
Growth (TTM | estimate)
Revenue
-25.9% | -6.5%
EBITDA
-371.1% | -86.7%
EBIT
9.5% | -606.4%
Net Income
18.3% | 71.3%
Free Cash Flow
-200.0%
Margin (TTM | estimate)
Gross
56.8%
EBITDA
-3.2% | 0.7%
EBIT
-8.8%
Net
-49.0% | -14.4%
Free Cash Flow
-0.9%
More
EPS
$-4.2
FCF per Share
$-0.1
Short interest
3.0%
Employees
288
Rev per Employee
$420.0k
Show more

Is Anika Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Anika Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Anika Therapeutics, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Anika Therapeutics, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Anika Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
124 124
26% 26%
100%
- Direct Costs 53 53
15% 15%
43%
70 70
32% 32%
57%
- Selling and Administrative Expenses 55 55
35% 35%
45%
- Research and Development Expense 26 26
16% 16%
21%
-3.91 -3.91
371% 371%
-3%
- Depreciation and Amortization 7.01 7.01
38% 38%
6%
EBIT (Operating Income) EBIT -11 -11
10% 10%
-9%
Net Profit -61 -61
18% 18%
-49%

In millions USD.

Don't miss a Thing! We will send you all news about Anika Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Anika Therapeutics, Inc. Stock News

Neutral
GlobeNewsWire
9 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options
Positive
Seeking Alpha
15 days ago
Anika Therapeutics is an HA-platform company with regenerative, OA pain, and non-orthopedic products. Their main line is called Integrity. But Hyalofast and Cingal can also eventually target the sizeable cartilage and OA markets. ANIK's Integrity outperformed since launch, and their regenerative solutions have grown YoY. That's why the company believes it can also tap into the tendon-augmentati...
Neutral
GlobeNewsWire
17 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options
More Anika Therapeutics, Inc. News

Company Profile

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Head office United States
CEO Cheryl Blanchard
Employees 288
Founded 1992
Website anika.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today